85 304

Cited 0 times in

Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.

Authors
Hahm, KB; Kim, DH; Lee, KM; Lee, JS; Surh, YJ; Kim, YB; Yoo, BM; Kim, JH; Joo, HJ; Cho, YK; Nam, KT; Cho, SW
Citation
Alimentary pharmacology & therapeutics, 18 Suppl 124-38, 2003
Journal Title
Alimentary pharmacology & therapeutics
ISSN
0269-28131365-2036
Abstract
BACKGROUND: It has been suggested that chronic, persistent, uncontrolled inflammations in the stomach could provide the basic step for the beginning of carcinogenesis. One of the potential clinical applications of rebamipide is the inhibition of the immunoinflammatory response in gastric mucosa imposed by Helicobacter pylori.



AIM: To determine the implications of long-term rebamipide treatment in H. pylori infection, we studied the underlying moleculo-pathological changes in gastric lesions in mice infected with H. pylori (SS1 strain), following this treatment.



METHODS: C57BL/6 mice were sacrificed 24 and 50 weeks after H. pylori infection, respectively. Colonization rates of H. pylori, degree of gastric inflammation and other pathological changes including atrophic gastritis and metaplasia, serum levels of IL-1beta, TNF-alpha, IFN-gamma and IL-10, mRNA transcripts of various mouse cytokines and chemokines, and NF-kappaB binding activities, and finally the presence of gastric adenocarcinoma were compared between an H. pylori infected group (HP), and an H. pylori infected group administered with long-term rebamipide-containing pellet diets (HPR).



RESULTS: Serum levels of IL-1beta, IFN-gamma and TNF-alpha, the gastric mucosal expression of ICAM-1, HCAM and MMP, and transcriptional regulation of NF-kappaB-DNA binding were all significantly decreased in the HPR group compared with the HP group. An RNase protection assay showed, in the rebamipide administered group, significantly decreased mRNA levels of apoptosis-related genes such as caspase-8, FasL, Fas, TRAIL and various cytokines genes such as IFN-gamma, RANTES, TNF-alpha, TNFR p75, IL-1beta. In the experiment designed to provoke gastric cancer through MNU treatment with H. pylori infection, the incidence of gastric carcinoma was not different in either group. However, long-term administration of rebamipide showed the advantage of decreasing precancerous lesions like chronic atrophic gastritis and showed molecular evidence of attenuation of proliferation.



CONCLUSION: The long-term administration of rebamipide should be considered in the treatment of H. pylori since it demonstrated molecular and biological advantages like a lessening of gastric inflammation and a possible chemopreventive effect.
MeSH terms
Alanine/analogs & derivatives*Alanine/therapeutic use*AnimalsAnti-Ulcer Agents/therapeutic use*Apoptosis/drug effectsBlotting, WesternCytokines/metabolismGastric Mucosa/microbiologyGastric Mucosa/pathologyGastritis/microbiologyGastritis/pathologyHelicobacter Infections/drug therapy*Helicobacter Infections/pathologyHelicobacter pylori*ImmunohistochemistryMatrix Metalloproteinases/metabolismMiceMice, Inbred C57BLNF-kappa B/metabolismProtein BindingProteins/metabolismQuinolones/therapeutic use*RNA, Messenger/metabolism
PMID
12925138
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Gastroenterology
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
AJOU Authors
함, 기백이, 기명유, 병무김, 진홍주, 희재조, 성원
Files in This Item:
Full-Text Not Available.txtDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse